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Abstract
Objectives To examine repeatability of parameters derived
from non-Gaussian diffusion models in data acquired in chil-
dren with solid tumours.
Methods Paediatric patients (<16 years, n=17) were scanned
twice, 24 h apart, using DWI (6 b-values, 0–1000 mm−2 s) at
1.5 T in a prospective study. Tumour ROIs were drawn (3
slices) and all data fitted using IVIM, stretched exponential,
and kurtosis models; percentage coefficients of variation (CV)
calculated for each parameter at all ROI histogram centiles,
including the medians.
Results The values for ADC, D, DDCα, α, and DDCK gave
CV<10 % down to the 5th centile, with sharp CV increases
below 5th and above 95th centile. K, f, and D* showed in-
creased CV (>30%) over the histogram. ADC,D, DDCα, and
DDCK were strongly correlated (ρ>0.9), DDCα and α were
not correlated (ρ=0.083).
Conclusion Perfusion- and kurtosis-related parameters
displayed larger, more variable CVacross the histogram, indi-
cating observed clinical changes outside of D/DDC in these
models should be interpreted with caution. Centiles below 5th
for all parameters show high CV and are unreliable as diffu-
sion metrics. The stretched exponential model behaved well
for both DDCα and α, making it a strong candidate for model-
ling multiple-b-value diffusion imaging data.
Key Points
• ADC has good repeatability as low 5th centile of the histo-
gram distribution.
• High CV was observed for all parameters at extremes of
histogram.
• Parameters from the stretched exponential model showed
low coefficients of variation.
• The median ADC, D, DDCα, and DDCK are highly corre-
lated and repeatable.
• Perfusion/kurtosis parameters showed high CV variations
across their histogram distributions.
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EPI echo-planar imaging
GRAPPA generalised autocalibrating partially
parallel acquisition acceleration
IRB institutional review board
IVIM intravoxel incoherent motion
MRI magnetic resonance imaging
ROI region of interest
SPAIR spectral adiabatic inversion recovery
Introduction
Diffusion-weighted imaging (DWI) is a functional magnetic
resonance imaging technique that is widely used in adult clin-
ical trials of novel anticancer therapeutics that may have cy-
tostatic rather than cytotoxic effect [1–5]. There is less expe-
rience of implementing DWI in paediatric oncology, where
introduction of new targeted anticancer therapeutics is a pri-
ority [6–8]. Similar to drug development in adults, functional
imaging, including DWI, may have a significant role in pro-
viding pharmacodynamic proof-of-target inhibition, or predic-
tive biomarkers to identify patients most likely to benefit from
a specific therapy.
DWI displays contrast arising from water protons that are
in motion, following the application of magnetic field gradi-
ents. This contrast informs on tissue cellularity, tortuosity of
the extracellular space, and integrity of cellular membranes.
Malignant tumours are characterised by increased cellularity
compared to their native tissues, and the impeded water diffu-
sion results in a lower apparent diffusion coefficient (ADC)
value. DWI has potential for oncological disease characterisa-
tion [9], with ADC having been reported as a potential marker
for response in high-grade paediatric brain tumours [10], but
there are still very few reports of functional imaging studies in
children with extracranial tumours [11]. Studies that have in-
vestigated the repeatability of functional imaging-derived pa-
rameters in adults [3, 12] do not necessarily reflect the added
challenges involved when scanning children.
Clinical studies commonly report summary statistics for
ADC within a region-of-interest (ROI), such as the mean or
median, but alternate properties of the ADC histogram may
give more insight into tumour heterogeneity and be of clinical
interest [5, 13–15]. Lower ADC regions within a tumour, in-
cluding the lowest centiles of the ADC histogram, may repre-
sent the highest cellularity and more aggressive disease.
Beyond the simple monoexponential ADC model, more com-
plex diffusion models may be applied to characterise observed
non-monoexponential signal attenuation in tissues, potentially
providing additional information relating to tumour perfusion,
or empirical parameters that capture the non-Gaussian charac-
ter of the water diffusion.
A recent study [16] demonstrated that in paediatric tu-
mours, the challenges of imaging children did not adversely
affect the feasibility or repeatability of median ADC measure-
ments; it is unknown whether such observations hold true for
more complex diffusion models. Further, there is interest in
moving from simple summary statistics (i.e. median values) to
evaluating the lowest parameter values that may reflect re-
gions within the tumour that are the most cellular and may
show differential response [17]. With increased interest in
such models and the use of summary statistics beyond the
mean and median, it is critical that derived diffusion metrics
be assessed for repeatability in the context of parameter
histograms.
The aim of this study is to evaluate the repeatability of
diffusion parameters derived from non-Gaussian diffusion
models in children with solid tumours, and to examine the
repeatability of each diffusion model parameter at different
centiles of the parameter histogram across the tumour ROI.
Specifically, the bi-exponential intravoxel incoherent motion
(IVIM) model [18], the stretched exponential model [19], and
the kurtosis model [20] will be applied to clinically acquired
multiple-b-value DWI data; since optimal model choice may
be dependent on pathology, and while practical limitations
prevent collection of a suitable range of bvalues for all DWI
models, the common physiological interpretations and suit-
ability judgements of these different models will be explicitly
avoided, with parameters from repeat baseline observations
being examined solely for repeatability.
Materials and methods
Patient population
The institutional review board (IRB) approved this prospec-
tive study, which included written consent for participation
obtained from each child’s parent or legal guardian, and assent
from each child, prior to inclusion. Study inclusion criteria
included (a) patients under 16 years, (b) confirmed diagnosis
of a solid tumour, (c) a measurable target lesion diameter of at
least 2 cm, and (d) MRI included as part of their standard care.
Exclusion criteria were (a) patients requiring general anaes-
thesia for imaging, (b) patients with impairment of renal func-
tion, (c) patients with previous allergy to contrast or any con-
traindications to MR imaging (this study also included DCE-
MRI, and a return visit solely for repeat DWI data was not
considered ethical), (d) patients with lungmetastases only, and
(e) patients with disease at locations likely to result in signif-
icant artefacts in diffusion imaging (motion or pulsatile arte-
facts, e.g. in lung or around the mediastinum). Scanning was
performed pre-treatment. This study focussed on diffusion
model parameter repeatability and behaviour in histogram
analysis, and explicitly does not interpret the parameter values
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themselves, allowing a broad range of pathologies to be eligi-
ble for inclusion in the study and thus collection of a sufficient
cohort. During the period January 2010 until August 2013, 17
patients with confirmed solid tumours were recruited.
Monoexponential analysis of DWI images from this patient
cohort has been previously reported by Miyazaki et al. [16],
but was confined to the ROI median of the monoexponential
diffusion model fitting (results reproduced here for reference
only), and analysis of concurrently acquired DCE-MRI data
not reported here.
Diffusion MR imaging
All imaging was performed on a 1.5 T MAGNETOMAvanto
MR system (Siemens Healthcare, Erlangen, Germany) using a
phased-array head coil (intracranial tumours) or a phased-
array body coil (extracranial tumours). DWI was performed
during the routine MRI scan, and repeated after 24 h with no
intervention. A free-breathing DWI protocol using a multi-
slice, single-shot echo-planar imaging (EPI) sequence was
used with the following parameters: TE 75 ms; TR 3500 ms;
matrix 128×128 (interpolated to 256×256); 24 contiguous 5-
mm slices; generalised autocalibrating partially parallel acqui-
sition (GRAPPA) acceleration factor 2; spectral adiabatic
inversion-recovery (SPAIR) fat suppression, and three signal
averages. Diffusion b values of 0, 50, 100, 300, 600, and
1000 mm−2 s were applied in three orthogonal directions
(50 mm−2 s being the minimum increment at the time of pro-
tocol design), and isotropic trace images calculated. The intra-
cranial field of view was 220×220 mm2 transverse, the extra-
cranial field of viewwas 300×300mm2 coronal. The imaging
volume was centred through the target lesion, and the total
time for the DWI protocol was 6 min.
Image analysis
For each patient, ROIs were manually drawn around the tu-
mour using all available imaging, and excluding necrotic
areas, by an expert radiologist (D.M.K., more than 10 years
of experience) for three central slices (where possible) in each
initial data set, and matching slices of the repeat data set.
Image analysis was performed offline using proprietary soft-
ware (ADEPT, The Institute of Cancer Research, UK).
Diffusion model fitting was performed on a voxel-by-voxel
basis using a Markov chain Monte Carlo approach as a robust
least-squares estimator, returning the following parameters
from the following models: (i) the IVIM, Eq. 1, giving the
slow diffusion component D, the fast pseudo-diffusion com-
ponentD*, the pseudo-diffusion fraction f, and the compound
parameter fD* [21]; (ii) the stretched exponential model,
Eq. 2, giving the distributed diffusion coefficient DDCα and
the stretching exponent α; (iii) the kurtosis model, Eq. 3, giv-
ing the diffusion coefficient DDCK and the kurtosis parameter
K. Reproduced here with permission for comparison are the
results from repeatability of monoexponential fitting for b -
values of at least 100 mm−2 s, to give apparent diffusion co-
efficient ADC100 (Eq. 4), as reported by Miyazaki et al. [16].
Sb ¼ S0: f :exp −b:D*
 þ 1− fð Þ:exp −b:Dð Þ  ð1Þ
Sb ¼ S0:exp − b:DDCαð Þαð Þ ð2Þ
Sb ¼ S0:exp −b:DDCK þ 16 :K
2:b2
 
ð3Þ
Sb ¼ S0:exp −b:ADCð Þ ð4Þ
In all equations, Sb is the signal intensity for a given b -
value, S0 is the signal at b=0 mm
−2 s, and b is the applied
bvalue (mm−2 s).
Statistical analysis
For each patient and parameter in each diffusion model, the
voxel-by-voxel results from within the tumour ROI from the
three slices were combined, and the percentiles (0th to 100th)
calculated in each case. Median values for each diffusion pa-
rameter were compared between the two visits (paired t test;
statistical significance in this study defined at p<0.05). The
repeatability of all diffusion parameters at each percentile was
found by calculating the repeated measures coefficient of var-
iation across the cohort, expressed as a percentage (see Eq. 5),
derived from σ2, the variance of the difference of the log-
transformed measurement values [22]. Lastly, the correlation
between all DWI parameters was examined using the average
of the median values from the repeat measurements.
CV ¼ 100%
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
exp
σ2
2
 
−1
s
ð5Þ
Results
Average patient age was 11 years (median; range 6–15 years);
details of the patient characteristics and their primary tumour
classification are given in Table 1. Patients were co-operative
and able to tolerate the free-breathing DWI protocol. For one
patient a repeat scan was logistically inconvenient, and the
DWI data in one patient suffered a technical failure, leaving
repeatability values of the DWI parameters derived from 15
pairs of measurements (seven intracranial, eight extracranial).
The median diffusion parameters are given in Table 2 for all
the models considered; the values across the cohort (given as
mean± s.d.) show a large variation, which is unsurprising giv-
en the varied pathologies included. There was no statistically
significant difference in the parameters in the repeat measures
(p>0.1 in all cases).
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The coefficients of variation (CV) and 95 % confi-
dence interval limits for the medians of all the derived
diffusion imaging parameters are summarised in
Table 3, with reference values from monoexponential
fitting [16]. Of all the parameters considered from the
different models, the most reproducible diffusion param-
eter for the full cohort was IVIM-derived D, with a CV
of 2.5 % comparable to the very good repeatability of
the monoexponential ADC. Both α and DDCα derived
from the stretched exponential model show good CV
(3.5 % and 4.3 % respectively), and DDCK derived
from the kurtosis model also has a similar CV of
6.1 %. The parameters associated with the fast pseudo-
diffusion fraction of the IVIM model, f and D*,
displayed a significantly higher CV (>30 %) for the full
cohort, as did the kurtosis parameter K. Within the sub-
groups for intra- and extracranial tumours, there is no
general pattern for comparison of repeatability for the
diffusion parameters, with the intracranial cohort
displaying lower CV for parameters from the IVIM
model, though not for the DDC calculated from either
the stretched exponential or kurtosis models.
The calculated correlation coefficients between parameters
in the different DWI models are given in Table 4 and show
high correlations (>0.9) between ADC100, IVIM D, DDCα,
and DDCK. The stretching exponent α showed moderate neg-
ative (<−0.6) correlation with K, f, and D*. Within models,
IVIM showed a moderate correlation between f and D*
(0.652).
Images at b=100 mm−2 s for matched slices on repeated
scans in an example patient (a relapsed rhabdomyosarcoma)
are given in Fig. 1; the images show an excellent visual agree-
ment. Representative diffusion data for a single voxel within
the same tumour displayed in Fig. 1 are shown in Fig. 2;
displaying the calculated diffusion models gives a visual indi-
cation of where the models differ, including the residuals of
the fitting, and how individual model parameters are sensitive
to specific regions of the diffusion decay curve.
The CVof the parameters from the different models at each
percentile are shown in Fig. 3, showing that the diffusion
parameters (ADC, D, DDCα, and DDCK) generally display
a characteristic ‘bathtub’ profile, where the smallest and larg-
est percentiles have CVs that are much larger, passing 50 %
and even approaching 100 %, either side of a substantially flat
region that includes the median. Other model parameters, with
the exception of α, display variation from this shape in a non-
intuitive way, as well as having higher CV.
Table 1 Patient cohort details
Sex/age (years) Pathology
Intracranial tumour
1 F/8 Anaplastic astrocytoma
2 M/7 Primitive neuroectodermal tumour
3 M/10 Glioblastoma multiforme
4 M/11 High grade glioma
5 F/9 Glioblastoma multiforme
6 M/8 Glioblastoma multiforme
7 M/15 Anaplastic astrocytoma
8 M/11 Astrocytoma
Extracranial tumour
9 M/7 Ganglioneuroblastoma
10 M/13 Spindle cell sarcoma
11 F/12 Ganglioneuroblastoma
12 M/14 Rhabdomyosarcoma
13 M/15 Sacral myxopapillary ependymoma
14 M/12 Intra-abdominal primitive
neuroectodermal tumour
15 M/6 Neuroblastoma
16 M/13 Rhabdomyosarcoma
17 M/14 Neuroendocrine tumour
Table 2 Mean ± s.d. of tumour ROImedian values for estimated DWI parameters across the cohort. High variation in these values is expected to have a
contribution from the variety of pathologies included within the repeatability study
Intracranial Extracranial Full cohort
Visit 1 Visit 2 Visit 1 Visit 2 Visit 1 Visit 2
ADC100 (10
−5 mm2 s−1) 175.8 ± 45.8 174.7 ± 47.2 104.2 ± 21.1 106.4 ± 26.1 142.4 ± 51.0 142.8 ± 51.5
f (%) 11.6 ± 6.9 8.6 ± 6.5 7.9 ± 3.5 7.5 ± 2.2 9.9 ± 5.8 8.1 ± 4.9
D (10−5 mm2 s−1) 166.5 ± 45.7 167.3 ± 47.2 99.0 ± 23.6 100.7 ± 23.4 135.0 ± 50.0 136.2 ± 50.3
D* (10−2 mm2 s−1) 1.5 ± 1.1 1.5 ± 0.9 1.1 ± 0.6 0.9 ± 0.3 1.3 ± 0.9 1.2 ± 0.7
fD* (10−4 mm2 s−1) 23.7 ± 22.8 20.8 ± 22.1 8.1 ± 4.6 7.9 ± 3.5 16.4 ± 18.3 14.8 ± 17.1
DDCα (10−5 mm2 s−1) 191.6 ± 49.1 185.9 ± 43.8 105.9 ± 25.2 109.0 ± 28.9 151.6 ± 58.6 150.0 ± 53.8
α 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.0 0.9 ± 0.1 0.9 ± 0.1
DDCK (10
−5 mm2 s−1) 225.8 ± 59.1 216.6 ± 46.5 123.3 ± 24.6 119.8 ± 17.1 178.0 ± 69.4 171.4 ± 60.9
Kurtosis (mm4 s−2) 1.1 ± 0.5 1.1 ± 0.6 1.4 ± 0.8 1.5 ± 0.6 1.3 ± 0.7 1.3 ± 0.7
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Discussion
The ability to effectively treat cancer is assisted at an individ-
ual level by the ability to detect changes in response bio-
markers following treatment. Functional imaging techniques
have the potential to supply useful imaging biomarkers that
provide insight into the mechanism and efficacy of cancer
treatment, prediction of patients more likely to respond to a
given therapy, as well as providing more physiological sensi-
tivity for earlier assessment of treatment response within and
between tumours.
The use of multiple-b-value DWI will substantially length-
en an imaging study; this is of greater concern when scanning
children, who are prone to greater movement and may find the
scan more distressing. Measurements using multiple bvalues,
however, allow more complex diffusion models to be applied,
which provide additional information reflecting the tumour
microenvironment, heterogeneity, and any differential pro-
gression or response.
In this study a six-b-value DWI protocol, lasting 6min, was
performed in children aged 6 to 15 years with confirmed solid
tumours on consecutive days without treatment intervention,
in order to assess diffusion parameter repeatability. All pa-
tients were able to co-operate throughout the entire imaging
protocol, and the functional imaging data obtained was of
sufficient quality to allow voxel-wise generation of parametric
maps; the repeatability of derived diffusion parameters such as
ADC was found to be comparable to that achieved in adult
cohorts [12, 16], indicating that multiple-b-value DWI is both
feasible and repeatable in this cohort.
Limitations of this study include combining both cranial
and extracranial tumours in the same evaluation, which may
preclude interpretation of DWI parameter values but does not
prevent assessment of repeatability behaviour. This study re-
quired children to have an additional MRI scan for research
purposes only, which resulted in additional ethical and logis-
tical challenges. Nonetheless, repeatability studies typically
do not require high numbers to be statistically robust. The
study was also limited by exclusion of younger patients, as
this would have required a second anaesthesia solely for the
research study.
The diffusion models examined in this study attempt to
describe any observed deviations from monoexponential
decay with b value. Estimates of parameters such as fD*
and K are more heavily influenced by a limited subset of
the b values (fD* is derived from small b values, whereas
K is not affected by low b values), and as observed in
these results may be expected to be subject to greater
variations (CV> 20 %, and up to 50 % for median) than
parameters influenced by a wider range of b values, such
as ADC100. The exponent of the monoexponential decay
coefficient, α, is influenced by all b values and has a CV
similar to that of the ADC and DDCα. There remains
much interest in the optimisation of b values for DWI
[23–25], and while the quality of the diffusion fitting
may depend on the choice of b values, it will also depend
on the nature of the target lesion/tissue and the diffusion
model choice. For studies that intend to model kurtosis,
for example, it may be desirable to replace the lower b -
value acquisitions with some at greater than 1000 mm−2 s
Table 3 Percentage coefficients of variation (%, with 95 % CI in
parentheses) for the ROI median of diffusion parameters in each model
Coefficient of variation (%, with 95 % CI)
Intracranial Extracranial Full cohort
ADC100 4.1 (2.6, 9.0) 2.4 (1.6, 4.9) 3.3 (2.4, 5.1)
f 37.6 (23.8, 94.9) 42.3 (27.3, 99.0) 41.0 (29.4, 68.6)
D 2.0 (1.3, 4.3) 3.0 (2.0, 6.0) 2.5 (1.8, 4.0)
D* 34.1 (21.6, 84.0) 37.7 (24.5, 85.7) 35.1 (25.4, 57.9)
fD* 26.9 (17.2, 63.6) 46.9 (30.1, 113.0) 38.1 (27.5, 63.4)
DDCα 5.0 (3.2, 11.0) 3.1 (2.0, 6.2) 4.3 (3.2, 6.8)
α 3.0 (1.9, 6.6) 4.1 (2.7, 8.4) 3.5 (2.6, 5.6)
DDCK 7.6 (4.9, 16.8) 4.9 (3.2, 10.0) 6.1 (4.4, 9.6)
Kurtosis 38.7 (24.4, 98.3) 59.3 (37.5, 157.6) 52.7 (37.5, 91.7)
ADC100 reproduced by permission from ref. [16]
Table 4 Pearson correlation
coefficient between DWI
parameters
ADC100 α DDCα IVIM D IVIM f IVIM D* DDCK K
ADC100 – 0.238 0.985 0.999 0.166 0.183 0.910 −0.686
α 0.238 – 0.083 0.238 −0.805 −0.794 −0.149 −0.712
DDCα 0.985 0.083 – 0.985 0.302 0.308 0.958 −0.608
IVIM D 0.999 0.238 0.985 – 0.151 0.194 0.906 −0.692
IVIM f 0.166 −0.805 0.302 0.151 – 0.652 0.530 0.391
IVIM D* 0.183 −0.794 0.308 0.194 0.652 – 0.483 0.270
DDCK 0.910 −0.149 0.958 0.906 0.530 0.483 – −0.439
K −0.686 −0.712 −0.608 −0.692 0.391 0.270 −0.439 –
Bold indicates |ρ| > 0.9, italic indicates |ρ| > 0.6
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[26], and IVIM may benefit from added smaller non-zero
b values that better capture the rapidly changing signal in
the pseudo-diffusion sensitive region [27]. The b values in
this study were chosen to capture a sufficient range of
b values to apply multiple model fitting, while remaining
within a clinically suitable time frame of 6 min, and the
lack of b values less than 50 mm−2 s and greater than
1000 mm−2 s may be considered a limitation of the study.
Accepting these b values as a compromise between cover-
age and available time, the comparison of diffusion
models shows that (excepting the stretched-exponential
model) the reproducibility of non-Gaussian diffusion
Fig. 1 Representative images
(b = 100 mm−2 s) from repeated
DWI scans (left day 0, right
day 1) of a patient with
rhabdomyosarcoma, showing
good visual agreement of patient/
tumour positioning
Fig. 2 Example plots of diffusion models of data from a single tumour
voxel from patient in Fig. 1, using a monoexponential, b stretched
exponential, c IVIM, and d kurtosis models. Narrow lines show c the
slow and fast components of the model, and d the first term in the kurtosis
model (DDCK). Residuals for the fitting are shown inset (units as main
axes)
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parameters may be limiting their utility, and so any dis-
cussion of b value number and values must be within that
context; optimisation may act to ameliorate this problem.
Examination of the parameter histograms shows an excel-
lent CV for diffusion parameters that are influenced by all
b values, such as ADC, (IVIM) D, DDCα, and DDCK.
Where diffusion coefficients inform on tissue cellularity and
extracellular space tortuosity, there is interest in moving from
the simple median (or mean) values and evaluating the lowest
parameter values that may reflect regions within the tumour
that are the most cellular [17]. From Fig. 3, it is remarkable
how far the low CV region extends throughout the ROI, and
indicates that centiles such as 25th, 10th, and 5th can be used
as reliably as the median. The CVs at the very lowest centiles
of the histograms, however, shows a high variation that will
include sensitivity to data quality, data support, consistency of
ROI, size of ROI, and tissue motion. For this reason, proper-
ties of these parameter histograms such as the minimum value
or below the 5th centile must be considered unreliable, and
inferences from such should be avoided. Similarly, the higher
CV observed for parameters f, D*, and K across the whole
histogram suggests that interpretation of changes in these
parameters as representing changes in underlying physiology
is problematic, and should be approached with caution.
Higher centiles also suffer the same increased variability and
are more likely to reflect outliers from fitting. The perfusion-
related parameters in the IVIM model, f and D*, and the kur-
tosis parameter K are influenced by smaller subsets of the data
(at lower and higher b value, respectively) and thus show
much greater variability across the histogram. Parameters that
have limits imposed during fitting, such as f and α, will have
artificially reduced CV near the limits, which is a reflection on
the characteristics of the data when using that model rather
than the utility of the ROI maximum as a functional imaging
biomarker. From these data, the stretched exponential model
appears to offer a robust and reliable diffusion model that goes
beyond that of the monoexponential model, and does not suf-
fer the weaknesses (covariance, high variance, instability
across parameter histogram) of IVIM and kurtosis parameters;
these observations for different centiles of histograms and
diffusion models are not expected to be specific to the paedi-
atric cohort.
High correlation coefficients between ADC100, D, DDCα,
and DDCK, (correlation coefficients above 0.9 in each case)
Fig. 3 Plots of CVat each centile of the histograms for each parameter in
the a monoexponential, b stretched exponential, c IVIM, and d kurtosis
diffusion models. The diffusion-related parameters exhibit low CVas low
as 5th percentile (expanded sections), but large variability is observed for
perfusion- and kurtosis-related parameters
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indicate that they are all reporting on the same phenomenon,
taken to be the Brownian diffusion of the observed spins.
Within different DWI models, the f and D* parameters from
the IVIM model have a correlation of 0.65, which although
not large indicates that they have an appreciable covariance
and are difficult to confidently report (from this acquisition
scheme). The very low correlation between α and DDCα in
the stretched exponential model (0.083) suggests that these
parameters are unique and identifiable parameters [28], asso-
ciated with independent tissue properties, and thus provide
more information than the simple ADC model [29]. The same
is true of the pseudo-diffusion-related parameters in the IVIM
model, and K in the kurtosis model, although the higher CVs
observed for these may limit their utility. It is interesting to
note that α correlates with both the perfusion and kurtosis
parameters of the other models, but the latter show only a very
low (<0.4) correlation to each other; this further indicates the
stretched exponential model as being suitable for capturing
deviation from purely Gaussian diffusion processes.
In conclusion, this study builds on using a well-tolerated
free-breathing diffusion imaging protocol to derive and exam-
ine the parameters derived from non-Gaussian diffusion
models, and demonstrates that while it is possible to obtain
repeatable functional parameters beyond themonoexponential
ADC, there are large variations seen in parameters that are
sensitive to a limited range of bvalues that may hinder useful
physiological interpretation. Median values for ADC, D,
DDCα, α, and DDCK had good repeatability (less than
10 %) in the ROI histogram as low as the 5th percentile, but
showed sharp increases in variance as the extreme values
within the ROI were approached, limiting the usefulness of
these values as biomarkers. The poor and variable repeatabil-
ity of perfusion- and kurtosis-related parameters found across
the ROI histogram demonstrates that observed changes in a
clinical setting should be interpreted with caution; in contrast,
both parameters in the stretched exponential model behaved
well. In practice, these results demonstrate the importance of
repeatability assessments when considering the interpretation
of metrics from advanced analysis of DWI data, including
histogram analysis and non-Gaussian diffusion models, in
clinical trials that contain functional MR imaging.
Acknowledgments The scientific guarantor of this publication is
Martin O. Leach. The authors of this manuscript declare no relationships
with any companies whose products or services may be related to the
subject matter of the article. This study has received funding fromCRUK
and EPSRC Cancer Imaging Centre in association with the Medical
Research Council and Department of Health (England) grant C1060/
A10334 and NHS funding to the NIHR Biomedical Research Centre
and the Clinical Research Facility in Imaging. Support also received for
the CR UK and EPSRC Paediatric Imaging Programme C7809/A10342.
Lucas Moreno and Lynley Marshall are funded by the Oak Foundation.
Neil P. Jerome is funded by Imagine for Margo; Andrew Pearson is
supported by Cancer Research UK (programme grant C1178/A10294)
– Chair in Paediatric Oncology. We acknowledge Experimental Cancer
Medicine Centre (ECMC) Network funding for support of early clinical
trials. Martin Leach is an NIHR Senior Investigator. No complex statisti-
cal methods were necessary for this paper. Institutional review board
approval was obtained. Written informed consent was obtained from all
subjects (patients) in this study. Monoexponential diffusion modelling of
tumours from this cohort has been previously reported (ref. 16), and those
results are included here for reference by permission of the authors.
Methodology: prospective, observational, performed at one institution.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Desar IME, ter Voert EGW, Hambrock T, van Asten JJ, van
Spronsen DJ, Mulders PF et al (2001) Functional MRI techniques
demonstrate early vascular changes in renal cell cancer patients
treated with sunitinib: a pilot study. Cancer Imaging 11:259–265
2. Jain R, Scarpace LM, Ellika S, Torcuator R, Schultz LR, Hearshen
D et al (2010) Imaging response criteria for recurrent gliomas treat-
ed with bevacizumab: role of diffusion weighted imaging as an
imaging biomarker. J Neurooncol 96(3):423–431
3. Koh DM, Blackledge M, Collins DJ, Padhani AR, Wallace T,
Wilton B et al (2009) Reproducibility and changes in the apparent
diffusion coefficients of solid tumours treated with combretastatin
A4 phosphate and bevacizumab in a two-centre phase I clinical
trial. Eur Radiol 19:2728–2738
4. Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X et al
(2012) Apparent diffusion coefficient histogram analysis stratifies
progression-free and overall survival in patients with recurrent
GBM treated with bevacizumab: a multi-center study. J
Neurooncol 108:491–498
5. Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ,
Woodworth DC et al (2014) Pretreatment ADC histogram analysis
is a predictive imaging biomarker for bevacizumab treatment but
not chemotherapy in recurrent glioblastoma. AJNR Am J
Neuroradiol 35(4):673–679
6. Norris RE, Adamson PC (2012) Challenges and opportunities in
childhood cancer drug development. Nat Rev Cancer 12(11):776–782
7. Vassal G, Zwaan CM, Ashley D, Le Deley MC, Hargrave D, Blanc
P et al (2013) New drugs for children and adolescents with cancer:
the need for novel development pathways. Lancet Oncol 14(3):
e117–e124
8. Boklan J (2006) Little patients, losing patience: pediatric cancer
drug development. Mol Cancer Ther 5(8):1905–1908
9. Jost SC, Ackerman JW, Garbow JR, Manwaring LP, Gutmann DH,
McKinstry RC (2008) Diffusion-weighted and dynamic contrast-
enhanced imaging as markers of clinical behavior in children with
optic pathway glioma. Pediatr Radiol 38(12):1293–1299
10. Gutierrez DR, Manita M, Jaspan T, Dineen RA, Grundy RG, Auer
DP (2013) Serial MR diffusion to predict treatment response in
high-grade pediatric brain tumors: a comparison of regional and
voxel-based diffusion change metrics. Neuro Oncol 15(8):981–989
11. Peet AC, Arvanitis TN, Leach MO, Waldman AD (2012)
Functional imaging in adult and paediatric brain tumours. Nat
Rev Clin Oncol 9(12):700–711
12. Nathan P, Zweifel M, Padhani AR, Koh D-M, Ng M, Collins DJ
et al (2012) Phase I trial of combretastatin A4 phosphate (CA4P) in
352 Eur Radiol (2017) 27:345–353
combination with bevacizumab in patients with advanced cancer.
Clin Cancer Res 18(12):3428–3439
13. Pope WB, Kim HJ, Alger J, Brown MS, Gjertson D, Sai V et al
(2009) Recurrent glioblastoma multiforme: ADC histogram analy-
sis predicts response to bevacizumab treatment. Neuroradiology
252(1):182–189
14. Song YS, Choi SH, Park C-K, Yi KS, Lee WJ, Yun TJ et al (2013)
True progression versus pseudoprogression in the treatment of glio-
blastomas: a comparison study of normalized cerebral blood vol-
ume and apparent diffusion coefficient by histogram analysis.
Korean J Radiol 14(4):662–672
15. Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz
CS et al. Prostate cancer aggressiveness: assessment with whole-
lesion histogram analysis of the apparent diffusion coefficient.
271(1):143–152
16. Miyazaki K, Jerome NP, Collins DJ, Orton MR, D’Arcy JA,
Wallace T et al (2015) Demonstration of the reproducibility of
free-breathing diffusion-weighted MRI and dynamic contrast en-
hanced MRI in children with solid tumours: a pilot study. Eur
Radiol 25(9):2641–2650
17. Yankeelov TE, LepageM, Chakravarthy A, Broome EE, Niermann
KJ, Kelley MC et al (2007) Integration of quantitative DCE-MRI
and ADC mapping to monitor treatment response in human breast
cancer: initial results. Magn Reson Imaging 25(1):1–13
18. Le Bihan D, Breton E, Lallemand D, AubinM-L, Vignaud J, Laval-
JeantetM (1988) Separation of diffusion and perfusion in intravoxel
incoherent motion MR imaging. Radiology 168(2):497–505
19. Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde
JS (2003) Characterization of continuously distributed cortical wa-
ter diffusion rates with a stretched-exponential model. Magn Reson
Med 50(4):727–734
20. Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K (2005)
Diffusional kurtosis imaging: the quantification of non-Gaussian
water diffusion by means of magnetic resonance imaging. Magn
Reson Med 53:1432–1440
21. Le Bihan D, Turner R (1992) The capillary network: a link between
IVIM and classical perfusion. Magn Reson Med 27(1):171–178
22. Limpert E, Stahel WA, Abbt M (2001) Log-normal distributions
across the sciences: keys and clues. Bioscience 51(5):341
23. Lemke A, Stieltjes B, Schad LR, Laun FB (2011) Toward an opti-
mal distribution of b values for intravoxel incoherent motion imag-
ing. Magn Reson Imaging 29(6):766–776
24. Freiman M, Voss SD, Mulkern RV, Perez-Rossello JM, Callahan
MJ, Warfield SK (2012) In vivo assessment of optimal b-value
range for perfusion-insensitive apparent diffusion coefficient imag-
ing. Med Phys 39:4832
25. Zhang JL, Sigmund EE, Rusinek H, Chandarana H, Storey P, Chen
Q et al (2012) Optimization of b-value sampling for diffusion-
weighted imaging of the kidney. Magn Reson Med 67:89–97
26. Rosenkrantz AB, Padhani AR, Chenevert TL, Koh D-M, De
Keyzer F, Taouli B et al (2015) Body diffusion kurtosis imaging:
basic principles, applications, and considerations for clinical prac-
tice. J Magn Reson Imaging 42(5):1190–1202
27. Koh D-M, Collins DJ, Orton MR (2011) Intravoxel incoherent
motion in body diffusion-weighted MRI: reality and challenges.
Am J Roentgenol 196(6):1351–1361
28. Cobelli C, DiStefano JJ 3rd (1980) Parameter and structural
identifiability concepts and ambiguities: a critical review and anal-
ysis. Am J Physiol 239(1):R7–R24
29. Winfield JM, DeSouza NM, Priest AN, Wakefield JC, Hodgkin C,
Freeman S et al (2015) Modelling DW-MRI data from primary and
metastatic ovarian tumours. Eur Radiol 25:2033–2040
Eur Radiol (2017) 27:345–353 353
